| Analysis | Metabolite Name | Measured Value | Units | Brain region | Age | Gender |
|---|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1077170 | Peak height | NA | NA | NA |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1207789 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1235469 | Peak height | Cerebellum | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1359994 | Peak height | NA | NA | NA |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1551832 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1659196 | Peak height | Basal ganglia | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 1771077 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2070063 | Peak height | Thalamus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2106796 | Peak height | Medulla | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2187011 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2224221 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2492351 | Peak height | Cerebellum | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2493713 | Peak height | Medulla | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2529573 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2576911 | Peak height | Thalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2591005 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2596728 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2626047 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2638793 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2660562 | Peak height | Cerebral cortex | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2685779 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2693039 | Peak height | Cerebellum | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2733238 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2783681 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2861212 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2870926 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2901526 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 2948706 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3003624 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3118818 | Peak height | Basal ganglia | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3143741 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3145783 | Peak height | Thalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3161701 | Peak height | Medulla | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3169566 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3184668 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3209455 | Peak height | Hypothalamus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3214025 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3214749 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3222589 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3227532 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3253169 | Peak height | Midbrain | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3273644 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3282453 | Peak height | Midbrain | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3288681 | Peak height | Midbrain | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3295654 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3309647 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3321145 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3330110 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3330210 | Peak height | Cerebral cortex | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3333252 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3347037 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3366159 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3373268 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3378384 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3392317 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3398491 | Peak height | Thalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3432481 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3451147 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3465971 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3479208 | Peak height | Cerebellum | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3491126 | Peak height | Thalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3498564 | Peak height | Basal ganglia | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3506389 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3520189 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3540268 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3543433 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3547580 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3553494 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3564200 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3575190 | Peak height | Olfactory bulb | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3576297 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3591204 | Peak height | Cerebellum | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3591499 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3594789 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3596980 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3597298 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3597772 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3607471 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3625401 | Peak height | Cerebellum | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3638669 | Peak height | Cerebellum | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3654981 | Peak height | Basal ganglia | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3657369 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3666208 | Peak height | Olfactory bulb | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3681626 | Peak height | Basal ganglia | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3682187 | Peak height | Cerebellum | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3683190 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3684642 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3686392 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3705420 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3725311 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3728852 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3743017 | Peak height | Cerebral cortex | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3743586 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3744550 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3761103 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3763619 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3765471 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3774860 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3790700 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3796745 | Peak height | Cerebral cortex | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3801546 | Peak height | Pons | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3810019 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3813275 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3814655 | Peak height | Medulla | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3815206 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3831539 | Peak height | Midbrain | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3834114 | Peak height | Basal ganglia | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3847767 | Peak height | Basal ganglia | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3849292 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3853499 | Peak height | Hippocampus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3855458 | Peak height | Olfactory bulb | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3858915 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3879434 | Peak height | Midbrain | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3912691 | Peak height | Cerebellum | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3913107 | Peak height | Hippocampus | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3920661 | Peak height | Olfactory bulb | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3924626 | Peak height | Cerebral cortex | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3939118 | Peak height | Cerebral cortex | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3947660 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3949713 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3950575 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3951933 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3956108 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3958546 | Peak height | Hypothalamus | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 3984674 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4001986 | Peak height | Hypothalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4008907 | Peak height | Pons | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4013845 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4022749 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4029283 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4032928 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4046192 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4055956 | Peak height | Cerebellum | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4063979 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4105098 | Peak height | Hypothalamus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4113241 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4150490 | Peak height | Hippocampus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4151847 | Peak height | Midbrain | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4153969 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4162468 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4171467 | Peak height | Medulla | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4174386 | Peak height | Basal ganglia | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4174558 | Peak height | Pons | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4179793 | Peak height | Hypothalamus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4186453 | Peak height | Medulla | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4188972 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4193945 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4198281 | Peak height | Cerebral cortex | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4202274 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4214270 | Peak height | Midbrain | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4217058 | Peak height | Olfactory bulb | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4219529 | Peak height | Thalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4223408 | Peak height | Midbrain | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4239992 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4240941 | Peak height | Midbrain | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4246995 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4256665 | Peak height | Midbrain | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4260392 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4266293 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4267560 | Peak height | Olfactory bulb | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4312335 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4319511 | Peak height | Cerebellum | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4325906 | Peak height | Hypothalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4329274 | Peak height | Medulla | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4339732 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4340230 | Peak height | Hippocampus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4358623 | Peak height | Basal ganglia | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4365575 | Peak height | Thalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4385770 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4390705 | Peak height | Medulla | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4422081 | Peak height | Cerebellum | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4425898 | Peak height | Pons | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4438838 | Peak height | Hypothalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4454448 | Peak height | Hippocampus | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4458511 | Peak height | Cerebral cortex | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4461882 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4469856 | Peak height | Pons | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4478316 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4478376 | Peak height | Cerebellum | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4486608 | Peak height | Cerebellum | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4513417 | Peak height | Cerebellum | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4514048 | Peak height | Cerebral cortex | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4529860 | Peak height | Midbrain | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4540499 | Peak height | Olfactory bulb | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4542693 | Peak height | Olfactory bulb | 59 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4563987 | Peak height | Hypothalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4592808 | Peak height | Basal ganglia | 16 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4612003 | Peak height | Medulla | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4625975 | Peak height | Hippocampus | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4639686 | Peak height | Pons | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4658046 | Peak height | Cerebellum | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4659945 | Peak height | Basal ganglia | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4688854 | Peak height | Medulla | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4691026 | Peak height | Hypothalamus | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4696009 | Peak height | Hypothalamus | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4717278 | Peak height | Medulla | 59 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4736815 | Peak height | Cerebral cortex | 3 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4739613 | Peak height | Hypothalamus | 3 weeks | Female |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4758293 | Peak height | Medulla | 16 weeks | Male |
| Reversed phase NEGATIVE ION MODE | FA 16:1; (palmitoleic acid) | 4766910 | Peak height | Thalamus | 16 weeks | Male |
Return to search page
